Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, FEA

Sun Nuclear's SunCHECKtm Platform Surpasses 1,000 Users Globally as New v3.1 Release Enhances Customization


MELBOURNE, Fla., Jan. 11, 2021 /PRNewswire/ -- Sun Nuclear Corporation announced today that its SunCHECKtm Quality Management Platform user base now exceeds 1,000 users globally in nearly 60 countries. SunCHECK automates and integrates Quality Management, enabling Radiation Therapy departments to standardize Patient and Machine Quality Assurance (QA) workflows among staff, machines, and locations. With the latest version 3.1 software release, SunCHECK users have even more flexibility to support their unique requirements.

Clinics worldwide rely on SunCHECK for a real-time understanding of their Patient and Machine QA ? consolidated in a single, browser-based platform.

SunCHECKtm Patient incorporates Plan Checks, Secondary Calculations, Pre-Treatment QA and In-Vivo Monitoring all in a single workflow. SunCHECKtm Machine integrates all Machine QA needs, including Daily, Monthly, and Annual QA; automated imaging, MLC and VMAT QA; and data trending. Plus, device integration with Daily QAtm 3, IC PROFILERtm and ArcCHECK® enables further automation and centralization of data.

"As we expand SunCHECK's capabilities, we are adding and enhancing features that improve workflow and meet the unique needs of Radiation Therapy departments worldwide," said Jeff Simon, CEO of Sun Nuclear. "We continue to hear from SunCHECK users how the Platform has helped them standardize and streamline their Quality Management, and has offered remote QA capabilities over this past year as teams looked to stagger staff time in the clinic."

The latest v3.1 software release brings 50+ feature enhancements. For Patient QA, key enhancements include Monte Carlo-based secondary dose calculation for Accuray Radixact® and TomoTherapy® plans created with a precision Treatment Planning System, and structure and alias improvements. For Machine QA, expanded custom task and custom reporting functionality adds:

For SunCHECK users in Germany, the new release offers DIN protocol baseline templates, with more than 85 DIN tasks.

"I am pleased we can offer this new enhancement to our customers in Germany. We engaged several clinics for an early test phase of the new DIN protocol templates and they were excited about our approach," notes Thorsten Bentzien, Sun Nuclear's Commercial Director for Germany & Austria.

SunCHECK provides flexibility and scalability; from one module for one linac, to the full platform for multiple linacs, and anything in between. Learn more: sunnuclear.com/suncheck.

About Sun Nuclear Corporation

Sun Nuclear provides innovative solutions for Radiation Therapy and Diagnostic Imaging centers. Our mission is to enable healthier lives by improving the avoidance, detection and treatment of cancer. More than 5,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, we aim to ease technology adoption, enhance workflows and improve outcomes ? so that healthcare providers can achieve real results for Patient Safety. Visit us: sunnuclear.com. Follow us: @sunnuclear.

Contact:
Kevin O'Malley, Sun Nuclear Corporation, +1 (321) 259 6862 x1238, [email protected]

SOURCE Sun Nuclear Corporation


These press releases may also interest you

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...

10 mai 2024
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

10 mai 2024
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

10 mai 2024
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

10 mai 2024
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

10 mai 2024
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...



News published on and distributed by: